Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about ...

Plants face simultaneous abiotic (drought, salinity, heat) and biotic (pathogens, pests) stresses in natural and agricultural ...

Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and ...

Scientists achieved a breakthrough. They bred healthy, fertile mice using DNA from two sperm cells. This was done through ...

Researchers used epigenome engineering and CRISPR to reprogram sperm DNA, allowing embryos to develop with only fathers.

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...

The study shows that mice born without a mother can not only survive but also grow up to have their own offspring, opening ...

The new research advances epigenetic programming as a reproductive tool to breed motherless mice without compromising on ...

Biotech firms focused on gene therapies traded higher after Eli Lilly (NYSE:LLY) agreed to acquire Boston-based gene-editing startup Verve Therapeutics (NASDAQ:VERV) for a total consideration of up to ...

CRISPR-based screening identifies H2AZ1 as a driver of cellular senescence. (A) Schematic of CRISPR-based loss-of-function (LOF) screening for histone variant-associated genes (HVRGs) to identify ...

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an annualized growth rate of approximately 63% over a decade. This level of ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...